Cargando…

Prevalence of APC and PTEN Alterations in Urachal Cancer

Urachal carcinoma (UrC) is a rare tumor with remarkable histological and molecular similarities to colorectal cancer (CRC). Adenomatous polyposis coli (APC) is the most frequently affected gene in CRC, but the prevalence and significance of its alterations in UrC is poorly understood. In addition, l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagy, Nikolett, Reis, Henning, Hadaschik, Boris, Niedworok, Christian, Módos, Orsolya, Szendrői, Attila, Bíró, Krisztina, Hager, Thomas, Herold, Thomas, Ablat, Jason, Black, Peter C., Okon, Krzysztof, Tolkach, Yuri, Csizmarik, Anita, Oláh, Csilla, Keresztes, David, Bremmer, Felix, Gaisa, Nadine T., Kriegsmann, Joerg, Kovalszky, Ilona, Kiss, András, Tímár, József, Szász, Marcell A., Rink, Michael, Fisch, Margit, Nyirády, Péter, Szarvas, Tibor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471184/ https://www.ncbi.nlm.nih.gov/pubmed/32754865 http://dx.doi.org/10.1007/s12253-020-00872-6

Ejemplares similares

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas
por: Varadi, Melinda, et al.
Publicado: (2023)

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance
por: Módos, Orsolya, et al.
Publicado: (2016)

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients
por: Olah, Csilla, et al.
Publicado: (2020)

Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data
por: Reis, Henning, et al.
Publicado: (2018)

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy
por: Krafft, Ulrich, et al.
Publicado: (2021)

Correction to: COVID-19 research: promising tracks leading to uro-oncology
por: Fazekas, Tamás, et al.
Publicado: (2020)

COVID-19 research: promising tracks leading to uro-oncology
por: Tamás, Fazekas, et al.
Publicado: (2020)

Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma
por: Kovács, Petra Terézia, et al.
Publicado: (2022)

High-soluble CGA levels are associated with poor survival in bladder cancer
por: Szarvas, T, et al.
Publicado: (2019)

MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
por: Szarvas, Tibor, et al.
Publicado: (2020)

Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration‐resistant prostate cancer
por: Keresztes, Dávid, et al.
Publicado: (2021)

Serum and tissue syndecan-1 levels in renal cell carcinoma
por: Niedworok, Christian, et al.
Publicado: (2020)

Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer
por: Szendrői, Attila, et al.
Publicado: (2016)

A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
por: Neumann, Judith Martha, et al.
Publicado: (2021)

Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer
por: Csizmarik, Anita, et al.
Publicado: (2022)

Correction to: A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
por: Neumann, Judith Martha, et al.
Publicado: (2021)

Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study
por: Váradi, Melinda, et al.
Publicado: (2023)

Why are upper tract urothelial carcinoma two different diseases?
por: Szarvas, Tibor, et al.
Publicado: (2016)

High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma
por: Széles, Ádám, et al.
Publicado: (2022)

Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis
por: Széles, Ádám, et al.
Publicado: (2022)

Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
por: Szarvas, Tibor, et al.
Publicado: (2022)

Bosniak category III cysts are more likely to be malignant than we expected in the era of multidetector computed tomography technology
por: Bata, Pal, et al.
Publicado: (2014)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
por: Olah, Csilla, et al.
Publicado: (2022)

Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis
por: Fazekas, Tamás, et al.
Publicado: (2022)

Stone extraction with loop ureteral catheter versus ureteroscopy in small distal ureteral stones—retrospective comparison of 547 consecutive patients
por: Rehme, Christian, et al.
Publicado: (2021)

Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
por: Szarvas, Tibor, et al.
Publicado: (2019)

Less invasive treatment option for renal carcinoma with venous tumor thrombus
por: Nagy, Zoltán, et al.
Publicado: (2014)

Urachal Actinomycosis Mimicking a Urachal Tumor
por: Lim, Kyoung Taek, et al.
Publicado: (2010)

Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival
por: Tóth, Gábor, et al.
Publicado: (2022)

A Rare Cause of Urachal Adenocarcinoma: Urachal Diverticle
por: Çiçek, Tufan, et al.
Publicado: (2013)

Urachal carcinoma
por: Abeygunasekera, Anuruddha M., et al.
Publicado: (2013)

Urachal Fistulæ
Publicado: (1930)

Identifying Resistance Mechanisms against Five Tyrosine Kinase Inhibitors Targeting the ERBB/RAS Pathway in 45 Cancer Cell Lines
por: Pénzváltó, Zsófia, et al.
Publicado: (2013)

Clinical comparison of patients with benign urachal masses versus urachal carcinomas
por: Bi, Xing, et al.
Publicado: (2017)

Tuberculosis of the urachal cyst
por: Jindal, Tarun, et al.
Publicado: (2013)

Urachal xanthogranuloma: a rare but important case presenting as a urachal mass
por: Jain, Kunal, et al.
Publicado: (2023)

Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma: A Combined Cohort Analysis, Systematic Review, and Meta-Analysis
por: Kubik, András, et al.
Publicado: (2023)

Treatment of Infected Urachal Cysts
por: Yoo, Koo Han, et al.
Publicado: (2006)

Acute presentation of Urachal remnant
por: Kini, V, et al.
Publicado: (2013)

Urachal carcinoma: imaging findings
por: Monteiro, Vanessa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_etbvh5g9sr6osrh22r9da9u8rm